Sandra Breber serves as Executive at Augmedix, Inc., where they oversee executive responsibilities. Since joining the company, Sandra Breber has executed 5 insider transactions totaling $52.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 15, 2024 involved selling 2,351 shares valued at $5.3K.
Sandra Breber currently holds 20,295 shares of Augmedix, Inc. (AUGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sandra Breber has been a net buyer of AUGX stock. They have purchased $50.0K and sold $2.8K worth of shares.
Sandra Breber's most recent insider trade was on Aug 15, 2024, when they sold 2,351 shares at $2.27 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Planned |
| May 15, 2024 | AUGX | $0 | Option Exercise | 6,250 | $N/A | Planned |
| May 15, 2024 | AUGX | $2.8K | Sale | 2,354 | $1.19 | Planned |
| Oct 28, 2021 | AUGX | $50.0K | Purchase | 12,500 | $4.00 | Discretionary |